Healthcare names lead premarket gainers

|About: Axsome Therapeutics (AXSM)|By:, SA News Editor

Axsome Therapeutics (NASDAQ:AXSM) +189% on positive AXS-05 data.

Luxoft Holding (NYSE:LXFT) +82% as DXC acquisition.

Loxo Oncology (NASDAQ:LOXO) +66%. on being acquired by Eli Lilly.

Sage Therapeutics (NASDAQ:SAGE) +42% on positive SAGE-217 data.

QEP Resources (NYSE:QEP) +39% as Elliott Management offers to buy.

Insmed (NASDAQ:INSM) +31% on Arikayce update.

Neptune Wellness Solutions (NASDAQ:NEPT) +24% on Canadian cannabis license.

Clovis Oncology (NASDAQ:CLVS) +13% on announcing revenue for 4Q18 and FY18.

IZEA Worldwide (NASDAQ:IZEA) +12% on record Q4 bookings growth of 115%.

Astrotech (NASDAQ:ASTC) +9% as 1st detect passes Europe's ECAC cargo test and looks to receive ECAC certification in the near-term.

KemPharm (NASDAQ:KMPH) +8% on FDA nod for new Apadaz doses.

Roku (NASDAQ:ROKU) +9% on announcing Westinghouse Roku TV partnership.

Exact Sciences (NASDAQ:EXAS) +8% on Q4 and FY18 sales.

Epizyme (NASDAQ:EPZM) +7%.

Array BioPharma (NASDAQ:ARRY) +7%.

Axovant Sciences (NASDAQ:AXON) +6%.

TransEnterix (NYSEMKT:TRXC) +5% on corporate update.

Subscribe for full text news in your inbox